日本京都大学iPS细胞研究所日前发表公报说,在培育诱导多能干细胞(iPS细胞)的时候,使用基因“L-Myc”代替基因“c-Myc”,可大幅降低iPS细胞癌变的风险,从而有效生成安全的iPS细胞。
该所教授山中伸弥2007年通过向人体皮肤细胞植入4个基因,培育出了类似胚胎干细胞的iPS细胞。但4个基因中的“c-Myc”基因有引发癌症的危险。虽然只植入其他3个基因也能培育出iPS细胞,但是生成的iPS细胞质量较差。
在本次研究中,山中伸弥率领的研究小组发现,基因“L-Myc”的结构与“c-Myc”非常相近。为了比较两种基因的功能,研究人员分别把这两种基因搭配其他3种基因一起植入实验鼠体细胞中,培育出iPS细胞。然后再令iPS细胞分化成生殖细胞,并培育出实验鼠。约两年后,用含“c-Myc”基因的iPS细胞培育的实验鼠有70%以上出现了肿瘤,而利用“L-Myc”基因的则几乎未发现肿瘤。
同时,新方法培育iPS细胞的效率也比较高。与使用原先的培育方法相比,使用新方法可使实验鼠体细胞转化为iPS细胞的比例提高到4倍左右,人类体细胞转化为iPS细胞的比例提高到3倍左右。与只植入其他3种基因相比,使用新方法iPS细胞分化成实验鼠生殖细胞的比例约是前者的5倍。
参与研究的讲师中川诚人指出:“这项技术大体上解决了iPS细胞发育成癌细胞的问题,具有重要意义。”(生物谷Bioon.com)
生物谷推荐原文出处:
PNAS doi: 10.1073/pnas.1009374107
Promotion of direct reprogramming by transformation-deficient Myc
Masato Nakagawa a , 1 , Nanako Takizawa a , Megumi Narita a , b , Tomoko Ichisaka a , b , and Shinya Yamanaka a , b , c , d , 1
aCenter for iPS Cell Research and Application and
bInstitute for Integrated Cell–Material Sciences, Kyoto University, Kyoto 606-8507, Japan;
cYamanaka iPS Cell Special Project, Japan Science and Technology Agency, Kawaguchi 332-0012, Japan; and
d Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158
Induced pluripotent stem cells (iPSCs) are generated from mouse and human fibroblasts by the introduction of three transcription factors: Oct3/4, Sox2, and Klf4. The proto-oncogene product c-Myc markedly promotes iPSC generation, but also increases tumor formation in iPSC-derived chimeric mice. We report that the promotion of iPSC generation by Myc is independent of its transformation property. We found that another Myc family member, L-Myc, as well as c-Myc mutants (W136E and dN2), all of which have little transformation activity, promoted human iPSC generation more efficiently and specifically compared with WT c-Myc. In mice, L-Myc promoted germline transmission, but not tumor formation, in the iPSC-derived chimeric mice. These data demonstrate that different functional moieties of the Myc proto-oncogene products are involved in the transformation and promotion of directed reprogramming.